Blocknomi
TLDR JNJ shares gain 0.35% as FDA approval adds a new head and neck cancer treatment. RYBREVANT FASPRO targets EGFR and MET in certain advanced head and neck cancers. The…
Related articles
-
Toronto FC, Whitecaps and CF Montréal: MLS Markets for Canadian Fans
Crypto Daily Published 07.11.2026 10:17
-
XRP Sunday Wallet Surge Makes Sustainability—not Size—the Next Test
The Crypto Basic Published 03.11.2026 14:55
-
Meta and Palantir Reject OKXICE Stock Tokenization Listings
Bitcoin.com Published 08.11.2026 04:30
-
Nvidia CEO Probe Hit Binance Stock Perps While Wall Street Was Closed
BeInCrypto Published 10.11.2026 01:57
-
Texas brothers sentenced to 15 years for holding Minnesota family at gunpoint in $8 million crypto heist
The Block Published 30.10.2026 16:26
-
BNB Price Holds Near $707 as Binance Withdrawals Resume in Phases
Blocknomi Published 01.11.2026 09:07
-
Datadog (DDOG) Stock: Plunges 14% Despite 35% Revenue Growth and $5.2B Cash Reserves in Q3 2026
Blocknomi Published 04.11.2026 16:21
-
Ukraine’s central bank rejects crypto bill over foreign token and monopoly risks
Crypto.News Published 05.11.2026 13:34